Long-term mental health service utilization among patients with diffuse large B-cell lymphoma: a population-based study. (PubMed, Leuk Lymphoma) - Oct 15, 2026 - "This population-based retrospective matched-cohort study used Ontario administrative data; patients treated with rituximab-based chemotherapy (2005-2017) were matched 1:4 (age/sex) to non-cancer controls and followed up to 15 years...Higher MHU was associated with younger age, female sex, lower income, and urban residence. DLBCL patients demonstrated persistently elevated MHU for up to 15 years post-treatment, underscoring the need for mental health integration into survivorship care."
Journal • B Cell Lymphoma • CNS Disorders • Diffuse Large B Cell Lymphoma • Hematological Malignancies • Lymphoma • Non-Hodgkin's Lymphoma • Oncology • Psychiatry
|
|
Anca Prica; Andrew Calzavara; Hari S Raman; Inna Y Gong; Kelvin K W Chan; Lee Mozessohn; Matthew C Cheung; Michael J Raphael; Ning Liu; Oreofe O Odejide; Paul Kurdyak
|